Metraipolis › archive › dc_dbdfcb7a0c54

A study of psychological pain in substance use disorder and its relationship to treatment outcome — Europe PMC PMID:31697679

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/31697679
DOI
10.1371/journal.pone.0216266
License (as archived)
CC0-1.0
Archived
2026-11-10T04:01:19.338Z
SHA-256 of the archived text
b3562a7808badf22eadb465e85b335f609482368bc5d9260fec9bb7ce92d567d
Stable URL of this page
https://metraipolis.com/documento/dc_dbdfcb7a0c54

How to cite

A study of psychological pain in substance use disorder and its relationship to treatment outcome — Europe PMC PMID:31697679 — Europe PMC (en), https://europepmc.org/article/MED/31697679 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_dbdfcb7a0c54 (Metraipolis archive dc_dbdfcb7a0c54, sha256 b3562a7808badf22eadb465e85b335f609482368bc5d9260fec9bb7ce92d567d)
BibTeX
@misc{dcdbdfcb7a0c54,
  title = {A study of psychological pain in substance use disorder and its relationship to treatment outcome — Europe PMC PMID:31697679},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/31697679},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_dbdfcb7a0c54; sha256 b3562a7808badf22eadb465e85b335f609482368bc5d9260fec9bb7ce92d567d},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31697679. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Substance Use Disorder (SUD) is a major public health concern affecting an estimated 22.5 million individuals in the United States. The primary aim of this study was to characterize psychological pain in a cohort of patients participating in outpatient treatment for SUD. A secondary aim was to determine the relationships between pre-treatment assessments of psychological pain, depression, anxiety and hopelessness with treatment retention time and completion rates. Data was analyzed from 289 patients enrolled in an outpatient community drug treatment clinic in Southern California, U.S. A previously determined threshold score on the Mee-Bunney Psychological Pain Assessment Scale (MBP) was utilized to group patients into high and low-moderate scoring subgroups. The higher pain group scored higher on measures of anxiety, hopelessness and depression compared to those in the low-moderate pain group. Additionally, patients scoring in the higher psychological pain group exhibited reduced retention times in treatment and more than two-fold increased odds of dropout relative to patients with lower pre-treatment levels of psychological pain. Among all assessments, the correlation between psychological pain and treatment retention time was strongest. To our knowledge, this is the first study to demonstrate that psychological pain is an important construct which correlates with relevant clinical outcomes in SUD. Furthermore, pre-treatment screening for psychological pain may help target higher-risk patients for clinical interventions aimed at improving treatment retention and completion rates.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2019 (prima pubblicazione 2019-11-07).
Identificativi: PMID 31697679 · PMCID PMC6837512 · DOI 10.1371/journal.pone.0216266.
Pagina: https://europepmc.org/article/MED/31697679 — https://doi.org/10.1371/journal.pone.0216266. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-10T03:57:55.863Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.